Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 5 Waldenstrom Macroglobulinemia 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, B-Cell 2 Recurrence 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, B-Cell 1 Hematologic Diseases 1

Interventions

fludarabine 3 Cyclophosphamide 3 obinutuzumab 2 acalabrutinib 2 ricolinostat 1 pirtobrutinib 1 idelalisib 1 ibrutinib 1 fludarabine phosphate 1 Rituximab 1 Mesna 1 Leukapheresis 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, B-Cell × pirtobrutinib × 30 days × Clear all

NCT07624799 2026-06-03

PACIFIC

French Innovative Leukemia Organisation

Phase 2 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡